Dow Up 0.11% Nasdaq Up 0.50%

Akebia Therapeutics, Inc. (AKBA)

-NasdaqGM
22.51 Up 0.66(3.02%) Aug 29, 4:00PM EDT
Prev Close:21.85
Open:22.08
Bid:16.00 x 100
Ask:N/A
1y Target Est:30.67
Beta:N/A
Earnings Date:Oct 6 - Oct 10 (Est.)
Day's Range:21.85 - 22.63
52wk Range:16.41 - 31.00
Volume:95,845
Avg Vol (3m):142,328
Market Cap:411.93M
P/E (ttm):N/A
EPS (ttm):-10.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AKBA

Comparison

Symbol% ChgMkt Cap
AKBAUp 3.02%411.93M
AMGNUp 0.50%105.87B
JNJUp 0.76%292.55B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.01
Quarterly EPS Est (Sep-14) :-0.45
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback